Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
This special issue of JCM ‘The Prevention and Treatment of Atherosclerosis’ will walk the Readers across novel diagnostic achievements in atherosclerosis and contemporary actions towards optimizing therapy.Everything begins with diagnosis. Accurate diagnostic tools and tests are of utmost importance. Contemporary research on microparticles, non-coding RNAs, proteomic characterization, …, offers detailed molecular characteristics of athero-thrombosis.Prevention is equally important as treatment. The impact of eating habits in prophylaxis of many pathologies, including cardiovascular disease has been documented.Then new pharmacological agents. Managing hypercholesterolemia with PCSK9 inhibitors, shown great potential in efficient lipid lowering to achieve LDL-C treatment goals, as well as reduction in cardiovascular mortality and morbidity.However, therapeutic goals accomplishment requires supervision. Arising number of data support that cardiovascular risk prediction can be improved with imaging modalities displaying atheroma: carotid plaque ultrasonography, coronary calcium score, intravascular ultrasonography, and optical coherent tomography or many others.As atherosclerosis is a progressive disease, it comes the time for more radical management, including endovascular and surgical intervention. There is field for new stent and equipment technologies, new surgical and endovascular techniques, supervision of endovascular procedures with IVUS, OCT, functional flow assessment or cell therapy.From diagnosis to risk stratification, elaborated prevention models, finally to modern and optimized therapeutic intervention.
Research & information: general --- familial hypercholesterolemia --- genetic screening --- atherosclerosis prevention --- early detection --- atherosclerosis --- cigarette smoking --- miR-27b --- peripheral artery disease --- subclinical atherosclerosis --- SCORE --- Framingham --- QRISK --- PROCAM --- cardiovascular risk --- pulse wave velocity --- intima media thickness --- malondialdehyde low-density lipoprotein --- high-risk plaque --- coronary computed tomography angiography --- statin --- cardiovascular risk factors --- heart failure --- major cardiac and cerebral ischemic events --- degenerative aortic stenosis --- risk stratification --- vascular resistance --- cardiovascular disease --- acute myocardial infarction --- intravascular imaging --- statins --- control-theoretic model --- logistic growth --- coronary artery disease --- fibrin clot --- fibrinolysis --- thromboembolism --- carotid intima-media complex --- carotid plaque --- major adverse cardiac and cerebral events --- prevention --- scores --- vitamin D --- myocardial infarction --- males --- Coronary Artery Surgery Study Score --- n/a
Choose an application
This special issue of JCM ‘The Prevention and Treatment of Atherosclerosis’ will walk the Readers across novel diagnostic achievements in atherosclerosis and contemporary actions towards optimizing therapy.Everything begins with diagnosis. Accurate diagnostic tools and tests are of utmost importance. Contemporary research on microparticles, non-coding RNAs, proteomic characterization, …, offers detailed molecular characteristics of athero-thrombosis.Prevention is equally important as treatment. The impact of eating habits in prophylaxis of many pathologies, including cardiovascular disease has been documented.Then new pharmacological agents. Managing hypercholesterolemia with PCSK9 inhibitors, shown great potential in efficient lipid lowering to achieve LDL-C treatment goals, as well as reduction in cardiovascular mortality and morbidity.However, therapeutic goals accomplishment requires supervision. Arising number of data support that cardiovascular risk prediction can be improved with imaging modalities displaying atheroma: carotid plaque ultrasonography, coronary calcium score, intravascular ultrasonography, and optical coherent tomography or many others.As atherosclerosis is a progressive disease, it comes the time for more radical management, including endovascular and surgical intervention. There is field for new stent and equipment technologies, new surgical and endovascular techniques, supervision of endovascular procedures with IVUS, OCT, functional flow assessment or cell therapy.From diagnosis to risk stratification, elaborated prevention models, finally to modern and optimized therapeutic intervention.
familial hypercholesterolemia --- genetic screening --- atherosclerosis prevention --- early detection --- atherosclerosis --- cigarette smoking --- miR-27b --- peripheral artery disease --- subclinical atherosclerosis --- SCORE --- Framingham --- QRISK --- PROCAM --- cardiovascular risk --- pulse wave velocity --- intima media thickness --- malondialdehyde low-density lipoprotein --- high-risk plaque --- coronary computed tomography angiography --- statin --- cardiovascular risk factors --- heart failure --- major cardiac and cerebral ischemic events --- degenerative aortic stenosis --- risk stratification --- vascular resistance --- cardiovascular disease --- acute myocardial infarction --- intravascular imaging --- statins --- control-theoretic model --- logistic growth --- coronary artery disease --- fibrin clot --- fibrinolysis --- thromboembolism --- carotid intima-media complex --- carotid plaque --- major adverse cardiac and cerebral events --- prevention --- scores --- vitamin D --- myocardial infarction --- males --- Coronary Artery Surgery Study Score --- n/a
Choose an application
This special issue of JCM ‘The Prevention and Treatment of Atherosclerosis’ will walk the Readers across novel diagnostic achievements in atherosclerosis and contemporary actions towards optimizing therapy.Everything begins with diagnosis. Accurate diagnostic tools and tests are of utmost importance. Contemporary research on microparticles, non-coding RNAs, proteomic characterization, …, offers detailed molecular characteristics of athero-thrombosis.Prevention is equally important as treatment. The impact of eating habits in prophylaxis of many pathologies, including cardiovascular disease has been documented.Then new pharmacological agents. Managing hypercholesterolemia with PCSK9 inhibitors, shown great potential in efficient lipid lowering to achieve LDL-C treatment goals, as well as reduction in cardiovascular mortality and morbidity.However, therapeutic goals accomplishment requires supervision. Arising number of data support that cardiovascular risk prediction can be improved with imaging modalities displaying atheroma: carotid plaque ultrasonography, coronary calcium score, intravascular ultrasonography, and optical coherent tomography or many others.As atherosclerosis is a progressive disease, it comes the time for more radical management, including endovascular and surgical intervention. There is field for new stent and equipment technologies, new surgical and endovascular techniques, supervision of endovascular procedures with IVUS, OCT, functional flow assessment or cell therapy.From diagnosis to risk stratification, elaborated prevention models, finally to modern and optimized therapeutic intervention.
Research & information: general --- familial hypercholesterolemia --- genetic screening --- atherosclerosis prevention --- early detection --- atherosclerosis --- cigarette smoking --- miR-27b --- peripheral artery disease --- subclinical atherosclerosis --- SCORE --- Framingham --- QRISK --- PROCAM --- cardiovascular risk --- pulse wave velocity --- intima media thickness --- malondialdehyde low-density lipoprotein --- high-risk plaque --- coronary computed tomography angiography --- statin --- cardiovascular risk factors --- heart failure --- major cardiac and cerebral ischemic events --- degenerative aortic stenosis --- risk stratification --- vascular resistance --- cardiovascular disease --- acute myocardial infarction --- intravascular imaging --- statins --- control-theoretic model --- logistic growth --- coronary artery disease --- fibrin clot --- fibrinolysis --- thromboembolism --- carotid intima-media complex --- carotid plaque --- major adverse cardiac and cerebral events --- prevention --- scores --- vitamin D --- myocardial infarction --- males --- Coronary Artery Surgery Study Score --- familial hypercholesterolemia --- genetic screening --- atherosclerosis prevention --- early detection --- atherosclerosis --- cigarette smoking --- miR-27b --- peripheral artery disease --- subclinical atherosclerosis --- SCORE --- Framingham --- QRISK --- PROCAM --- cardiovascular risk --- pulse wave velocity --- intima media thickness --- malondialdehyde low-density lipoprotein --- high-risk plaque --- coronary computed tomography angiography --- statin --- cardiovascular risk factors --- heart failure --- major cardiac and cerebral ischemic events --- degenerative aortic stenosis --- risk stratification --- vascular resistance --- cardiovascular disease --- acute myocardial infarction --- intravascular imaging --- statins --- control-theoretic model --- logistic growth --- coronary artery disease --- fibrin clot --- fibrinolysis --- thromboembolism --- carotid intima-media complex --- carotid plaque --- major adverse cardiac and cerebral events --- prevention --- scores --- vitamin D --- myocardial infarction --- males --- Coronary Artery Surgery Study Score
Choose an application
Contemporary healthcare trends indicate that many chronic and communicable diseases are related to lifestyle, stress, personal choices and systemic factors. In response to the shortfalls of modern medicine regarding the prevention of these diseases and the promotion of whole-person health, providers and consumers worldwide are exploring integrative, natural and complementary approaches to prevention, treatment and health promotion. These trends harbor the future of medicine. The issues of clinician burnout, high rates of adverse effects, high cost, and lack of rigorous methods to promote individual and collective immunity are addressed by leading physicians and scientists from around the world. The original research and reviews in this volume investigate efficacy, molecular mechanisms and hypotheses that suggest that traditional systems of medicine and health, e.g., Ayurveda, yoga, traditional Chinese medicine, and mind–body–lifestyle medicine, may offer preventive and cost-effective solutions to contemporary health care challenges. Integrating innovative health approaches with conventional medicine offers a whole system of medicine that encompasses the individual, family, community and environment—from single person to planetary health.
Medicine --- asthma --- diagnosis --- treatment strategies --- oxidative stress --- antioxidants --- microbiome --- Ayurveda --- gut bacteria --- diet --- lifestyle --- disease --- prevention --- integrative medicine --- Ayurgenomics --- genomics --- P4 medicine --- personalized medicine --- epigenetics --- genotype --- phenotype --- Prakriti --- doshas --- meditation --- focused attention --- open monitoring --- Transcendental Meditation --- antiviral --- medicinal plants --- pandemic --- SARS-CoV-2 --- zoonotic virus --- Artemisia --- Artemisinin --- ARTs --- phytochemicals --- chronic stress --- transcendental meditation --- gene expression --- energy metabolism --- biological aging --- epigenetic effects --- allostatic load --- complementary medicine --- plastic surgery --- anthroposophic medicine --- pandemic and women --- women and heart disease --- psychological effects of pandemic --- cardiac prevention --- risk of heart disease in women --- hypercholesterolemia --- ayurveda --- ayurvedic herbs --- systematic review --- meta-analysis --- integrative health --- whole-person health --- systems research --- reductionism --- complementary and alternative medicine --- healing --- healthcare transformation --- overview --- stroke --- vegetarian --- vegan --- dosha --- prakriti --- integrative nutrition --- asthma --- diagnosis --- treatment strategies --- oxidative stress --- antioxidants --- microbiome --- Ayurveda --- gut bacteria --- diet --- lifestyle --- disease --- prevention --- integrative medicine --- Ayurgenomics --- genomics --- P4 medicine --- personalized medicine --- epigenetics --- genotype --- phenotype --- Prakriti --- doshas --- meditation --- focused attention --- open monitoring --- Transcendental Meditation --- antiviral --- medicinal plants --- pandemic --- SARS-CoV-2 --- zoonotic virus --- Artemisia --- Artemisinin --- ARTs --- phytochemicals --- chronic stress --- transcendental meditation --- gene expression --- energy metabolism --- biological aging --- epigenetic effects --- allostatic load --- complementary medicine --- plastic surgery --- anthroposophic medicine --- pandemic and women --- women and heart disease --- psychological effects of pandemic --- cardiac prevention --- risk of heart disease in women --- hypercholesterolemia --- ayurveda --- ayurvedic herbs --- systematic review --- meta-analysis --- integrative health --- whole-person health --- systems research --- reductionism --- complementary and alternative medicine --- healing --- healthcare transformation --- overview --- stroke --- vegetarian --- vegan --- dosha --- prakriti --- integrative nutrition
Choose an application
The first national conference with international participation, “Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine”, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician–scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists.
Medicine --- Cardiovascular medicine --- metalloproteinases --- calcification --- atherosclerosis --- multiplex assay --- coronary heart disease --- aspirin --- resistance --- non-sensitivity --- antiplatelet --- light transmission aggregometry --- Plateletworks® --- familial hypercholesterolemia --- targeted sequencing technologies --- multiplex ligation-dependent probe amplification --- LDLR --- APOB --- ABCG5 --- APOC3 --- LPL --- SREBF1 --- rare variants --- coronary atherosclerosis --- ischemic heart disease --- saturated fatty acids --- monounsaturated fatty acids --- polyunsaturated fatty acids --- oxidative stress --- superoxide dismutase --- catalase --- glutathione peroxidase --- cumulative LDL-C level --- prognosis --- DNA methylation --- epigenetic age --- myocardial infarction --- acute coronary syndrome --- population --- nested case-control --- HAPIEE project --- HAPIEE study --- atrial fibrillation --- arterial hypertension --- obesity --- diabetes mellitus --- aging --- determinants --- prevalence --- Russian population cohort --- Cox regression analysis --- adiponectin --- leptin --- interleukin-6 --- epicardial adipose tissue --- perivascular adipose tissue --- circulating biochemical markers --- coronary atherosclerosis presence and severity --- integrated biomarker (i-BIO) --- validation --- visual markers --- lipoprotein(a) --- immune cells blood count --- metalloproteinases --- calcification --- atherosclerosis --- multiplex assay --- coronary heart disease --- aspirin --- resistance --- non-sensitivity --- antiplatelet --- light transmission aggregometry --- Plateletworks® --- familial hypercholesterolemia --- targeted sequencing technologies --- multiplex ligation-dependent probe amplification --- LDLR --- APOB --- ABCG5 --- APOC3 --- LPL --- SREBF1 --- rare variants --- coronary atherosclerosis --- ischemic heart disease --- saturated fatty acids --- monounsaturated fatty acids --- polyunsaturated fatty acids --- oxidative stress --- superoxide dismutase --- catalase --- glutathione peroxidase --- cumulative LDL-C level --- prognosis --- DNA methylation --- epigenetic age --- myocardial infarction --- acute coronary syndrome --- population --- nested case-control --- HAPIEE project --- HAPIEE study --- atrial fibrillation --- arterial hypertension --- obesity --- diabetes mellitus --- aging --- determinants --- prevalence --- Russian population cohort --- Cox regression analysis --- adiponectin --- leptin --- interleukin-6 --- epicardial adipose tissue --- perivascular adipose tissue --- circulating biochemical markers --- coronary atherosclerosis presence and severity --- integrated biomarker (i-BIO) --- validation --- visual markers --- lipoprotein(a) --- immune cells blood count
Choose an application
Contemporary healthcare trends indicate that many chronic and communicable diseases are related to lifestyle, stress, personal choices and systemic factors. In response to the shortfalls of modern medicine regarding the prevention of these diseases and the promotion of whole-person health, providers and consumers worldwide are exploring integrative, natural and complementary approaches to prevention, treatment and health promotion. These trends harbor the future of medicine. The issues of clinician burnout, high rates of adverse effects, high cost, and lack of rigorous methods to promote individual and collective immunity are addressed by leading physicians and scientists from around the world. The original research and reviews in this volume investigate efficacy, molecular mechanisms and hypotheses that suggest that traditional systems of medicine and health, e.g., Ayurveda, yoga, traditional Chinese medicine, and mind–body–lifestyle medicine, may offer preventive and cost-effective solutions to contemporary health care challenges. Integrating innovative health approaches with conventional medicine offers a whole system of medicine that encompasses the individual, family, community and environment—from single person to planetary health.
Medicine --- asthma --- diagnosis --- treatment strategies --- oxidative stress --- antioxidants --- microbiome --- Ayurveda --- gut bacteria --- diet --- lifestyle --- disease --- prevention --- integrative medicine --- Ayurgenomics --- genomics --- P4 medicine --- personalized medicine --- epigenetics --- genotype --- phenotype --- Prakriti --- doshas --- meditation --- focused attention --- open monitoring --- Transcendental Meditation --- antiviral --- medicinal plants --- pandemic --- SARS-CoV-2 --- zoonotic virus --- Artemisia --- Artemisinin --- ARTs --- phytochemicals --- chronic stress --- transcendental meditation --- gene expression --- energy metabolism --- biological aging --- epigenetic effects --- allostatic load --- complementary medicine --- plastic surgery --- anthroposophic medicine --- pandemic and women --- women and heart disease --- psychological effects of pandemic --- cardiac prevention --- risk of heart disease in women --- hypercholesterolemia --- ayurveda --- ayurvedic herbs --- systematic review --- meta-analysis --- integrative health --- whole-person health --- systems research --- reductionism --- complementary and alternative medicine --- healing --- healthcare transformation --- overview --- stroke --- vegetarian --- vegan --- dosha --- prakriti --- integrative nutrition --- n/a
Choose an application
The first national conference with international participation, “Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine”, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician–scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists.
Medicine --- Cardiovascular medicine --- metalloproteinases --- calcification --- atherosclerosis --- multiplex assay --- coronary heart disease --- aspirin --- resistance --- non-sensitivity --- antiplatelet --- light transmission aggregometry --- Plateletworks® --- familial hypercholesterolemia --- targeted sequencing technologies --- multiplex ligation-dependent probe amplification --- LDLR --- APOB --- ABCG5 --- APOC3 --- LPL --- SREBF1 --- rare variants --- coronary atherosclerosis --- ischemic heart disease --- saturated fatty acids --- monounsaturated fatty acids --- polyunsaturated fatty acids --- oxidative stress --- superoxide dismutase --- catalase --- glutathione peroxidase --- cumulative LDL-C level --- prognosis --- DNA methylation --- epigenetic age --- myocardial infarction --- acute coronary syndrome --- population --- nested case-control --- HAPIEE project --- HAPIEE study --- atrial fibrillation --- arterial hypertension --- obesity --- diabetes mellitus --- aging --- determinants --- prevalence --- Russian population cohort --- Cox regression analysis --- adiponectin --- leptin --- interleukin-6 --- epicardial adipose tissue --- perivascular adipose tissue --- circulating biochemical markers --- coronary atherosclerosis presence and severity --- integrated biomarker (i-BIO) --- validation --- visual markers --- lipoprotein(a) --- immune cells blood count --- n/a
Choose an application
Oxidative stress and altered redox signaling have been described in a plethora of pathological conditions. Redox-active molecules can thus potentially be used to modulate the etiology/progression of such diseases. Recent advances in molecular biology and pharmacology have strengthened this area of research by providing novel mechanistic insights. This book compiles a collection of 13 articles, covering a range of topics from in vitro studies to clinical research, focused on the potential therapeutic effects of either natural or synthetic compounds, applicable to different redox-related diseases.
non-small cell lung cancer --- cisplatin --- apurinic/apyrimidinic endonuclease 1 --- E3330 --- cytotoxicity --- apoptosis --- migration --- invasion --- oxidative stress --- sildenafil --- DNA damage --- systemic sclerosis --- bioactivity-based assays --- cyanidin --- metabolomics --- Rubus genus --- (poly)phenols --- yeast-based discovery platform --- withanolide --- breast cancer --- mitochondrial reactive oxygen species --- peroxiredoxin 3 --- pro-oxidant therapy --- thiostrepton --- GSH --- Cysteamine --- N-acetyl cysteine --- KEAP1 --- NRF2 --- ATF4 --- adipose-derived mesenchymal stem cell --- amniotic membrane-derived mesenchymal stem cell --- antioxidants --- assisted reproductive technology --- conditioned medium --- embryo --- in vitro culture --- in vitro fertilization --- BAPN --- cell invasion --- EMT --- lysyl-oxidase --- lysyl-oxidase like 2 --- metastases --- inhibitors --- doxorubicin --- chemoresistance --- redox signaling --- nuclear factor erythroid 2-related factor 2 (Nrf2) --- cancer therapy --- hydrogen sulfide --- reactive oxygen species --- H2S donors --- cardiorenal syndrome --- thiosulfate --- selenium-enriched Enterococcus faecium --- selenium-enriched Streptococcus thermophilus --- antioxidant capacity --- glutathione reductase --- glutathione peroxidase --- CD IGS rats --- lactic acid bacteria --- verbascoside --- hypercholesterolemia --- prostate cancer --- curcumin --- carnosic acid --- cell cycle --- OxPhos --- SGK1 --- n/a
Choose an application
The first national conference with international participation, “Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine”, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician–scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists.
metalloproteinases --- calcification --- atherosclerosis --- multiplex assay --- coronary heart disease --- aspirin --- resistance --- non-sensitivity --- antiplatelet --- light transmission aggregometry --- Plateletworks® --- familial hypercholesterolemia --- targeted sequencing technologies --- multiplex ligation-dependent probe amplification --- LDLR --- APOB --- ABCG5 --- APOC3 --- LPL --- SREBF1 --- rare variants --- coronary atherosclerosis --- ischemic heart disease --- saturated fatty acids --- monounsaturated fatty acids --- polyunsaturated fatty acids --- oxidative stress --- superoxide dismutase --- catalase --- glutathione peroxidase --- cumulative LDL-C level --- prognosis --- DNA methylation --- epigenetic age --- myocardial infarction --- acute coronary syndrome --- population --- nested case-control --- HAPIEE project --- HAPIEE study --- atrial fibrillation --- arterial hypertension --- obesity --- diabetes mellitus --- aging --- determinants --- prevalence --- Russian population cohort --- Cox regression analysis --- adiponectin --- leptin --- interleukin-6 --- epicardial adipose tissue --- perivascular adipose tissue --- circulating biochemical markers --- coronary atherosclerosis presence and severity --- integrated biomarker (i-BIO) --- validation --- visual markers --- lipoprotein(a) --- immune cells blood count --- n/a
Choose an application
Contemporary healthcare trends indicate that many chronic and communicable diseases are related to lifestyle, stress, personal choices and systemic factors. In response to the shortfalls of modern medicine regarding the prevention of these diseases and the promotion of whole-person health, providers and consumers worldwide are exploring integrative, natural and complementary approaches to prevention, treatment and health promotion. These trends harbor the future of medicine. The issues of clinician burnout, high rates of adverse effects, high cost, and lack of rigorous methods to promote individual and collective immunity are addressed by leading physicians and scientists from around the world. The original research and reviews in this volume investigate efficacy, molecular mechanisms and hypotheses that suggest that traditional systems of medicine and health, e.g., Ayurveda, yoga, traditional Chinese medicine, and mind–body–lifestyle medicine, may offer preventive and cost-effective solutions to contemporary health care challenges. Integrating innovative health approaches with conventional medicine offers a whole system of medicine that encompasses the individual, family, community and environment—from single person to planetary health.
asthma --- diagnosis --- treatment strategies --- oxidative stress --- antioxidants --- microbiome --- Ayurveda --- gut bacteria --- diet --- lifestyle --- disease --- prevention --- integrative medicine --- Ayurgenomics --- genomics --- P4 medicine --- personalized medicine --- epigenetics --- genotype --- phenotype --- Prakriti --- doshas --- meditation --- focused attention --- open monitoring --- Transcendental Meditation --- antiviral --- medicinal plants --- pandemic --- SARS-CoV-2 --- zoonotic virus --- Artemisia --- Artemisinin --- ARTs --- phytochemicals --- chronic stress --- transcendental meditation --- gene expression --- energy metabolism --- biological aging --- epigenetic effects --- allostatic load --- complementary medicine --- plastic surgery --- anthroposophic medicine --- pandemic and women --- women and heart disease --- psychological effects of pandemic --- cardiac prevention --- risk of heart disease in women --- hypercholesterolemia --- ayurveda --- ayurvedic herbs --- systematic review --- meta-analysis --- integrative health --- whole-person health --- systems research --- reductionism --- complementary and alternative medicine --- healing --- healthcare transformation --- overview --- stroke --- vegetarian --- vegan --- dosha --- prakriti --- integrative nutrition --- n/a
Listing 1 - 10 of 11 | << page >> |
Sort by
|